Browsing Barts Cancer Institute by Subject "brentuximab vedotin"
Now showing items 1-1 of 1
-
The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors
(e-Century Publishing Corporation, 2019)